Aphria (APHA)
US Market

Aphria (APHA) Stock Price & Analysis


APHA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.78 - $32.29
Previous Close$15.38
Average Volume (3M)20.08M
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)-10.0
Next EarningsN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.99
Shares OutstandingN/A
10 Day Avg. Volume5,462,144
30 Day Avg. Volume10,062,528
Standard DeviationN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside11.38% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9


What was Aphria’s price range in the past 12 months?
Aphria lowest stock price was $2.78 and its highest was $32.29 in the past 12 months.
    What is Aphria’s market cap?
    Aphria’s market cap is 4.87B.
      When is Aphria’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Aphria’s earnings last quarter?
      Currently, no data Available
      Is Aphria overvalued?
      According to Wall Street analysts Aphria’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Aphria pay dividends?
        Aphria does not currently pay dividends.
        What is Aphria’s EPS estimate?
        Aphria’s EPS estimate is -1.99.
          How many shares outstanding does Aphria have?
          Aphria has 316,800,000 shares outstanding.
            What happened to Aphria’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Aphria?
            Among the largest hedge funds holding Aphria’s share is Ardsley Advisory Partners. It holds Aphria’s shares valued at 157K.


              Aphria Stock Smart Score

              The Aphria stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description


              Aphria, Inc. engages in the production and supply of medical cannabis. It operates through the following segments: Cannabis Operations, Distribution Operations, and Business Under Development. The Cannabis Operations segment produces, distributes, and sells both medical and adult-use cannabis. The Distribution Operations segment are carried out through its wholly owned subsidiaries ABP, FL Group, and CC Pharma. The Distribution Under Development segment includes operations in which the firm has not received final licensing or has not commenced commercial sales from operations. The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada.


              Forecast EPS vs Actual EPS

              Currently, no data available
              Please return soon. This page is being updated.

              Similar Stocks
              Price & Change
              Silver One Resources

              Popular Stocks

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis